基于体素分析的治疗前PET/CT预测局部晚期头颈癌局部复发亚区
研究纳入26例放化疗后局部失败的头颈癌患者,通过配准治疗前与复发PET/CT识别复发体积,并提取治疗前PET体素特征训练随机森林模型预测复发亚区。15例配准精度足够者中,复发体积平均占初始肿瘤体积23%,SUV与MTV单独不足以识别复发区域,随机森林模型预测复发亚区的ROC曲线下面积中位数为0.71。
要点
- 复发体积平均占初始肿瘤体积23%,提示复发多位于原肿瘤内。
- SUV与MTV单独不足以识别复发区域。
- 随机森林模型预测复发亚区的AUC中位数为0.71,有潜力指导剂量提升。
核心结论
- 体素级分析FDG摄取特征可预测复发亚区,精度足以考虑在可能抗拒区域进行剂量提升。
研究设计与样本
- 回顾性纳入26例放化疗后局部失败的头颈癌患者,配准治疗前与复发PET/CT,提取治疗前PET体素特征训练随机森林模型。
主要发现
- 26例中15例配准精度足够,复发体积平均占初始肿瘤体积23%。
- SUV和MTV单独不足以识别复发区域。
- 随机森林模型使用15个结合影像组学与空间位置的参数,预测复发亚区的AUC中位数为0.71(范围0.14-0.91)。
关键数值与推荐
- 以SUVmax的50%为阈值加10 mm三维边距的MTV平均覆盖89.8%的复发体积和96.9%的初始肿瘤体积。
临床怎么用
- 治疗前FDG PET体素特征可用于识别可能复发的亚区,辅助选择剂量提升靶区。
局限性
- 仅15例配准精度足够的患者纳入分析,样本量小。
- AUC范围较宽(0.14-0.91),预测稳定性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Overall, 40% of patients with a locally advanced head and neck cancer (LAHNC) treated by chemoradiotherapy (CRT) present local recurrence within 2 years after the treatment. The aims of this study were to characterize voxel-wise the sub-regions where tumor recurrence appear and to predict their location from pre-treatment 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) images. MATERIALS AND METHODS: Twenty-six patients with local failure after treatment were included in this study. Local recurrence volume was identified by co-registering pre-treatment and recurrent PET/CT images using a customized rigid registration algorithm. A large set of voxel-wise features were extracted from pre-treatment PET to train a random forest model allowing to predict local recurrence at the voxel level. RESULTS: Out of 26 expert-assessed registrations, 15 provided enough accuracy to identify recurrence volumes and were included for further analysis. Recurrence volume represented on average 23% of the initial tumor volume. The MTV with a threshold of 50% of SUVmax plus a 3D margin of 10 mm covered on average 89.8% of the recurrence and 96.9% of the initial tumor. SUV and MTV alone were not sufficient to identify the area of recurrence. Using a random forest model, 15 parameters, combining radiomics and spatial location, were identified, allowing to predict the recurrence sub-regions with a median area under the receiver operating curve of 0.71 (range 0.14-0.91). CONCLUSION: As opposed to regional comparisons which do not bring enough evidence for accurate prediction of recurrence volume, a voxel-wise analysis of FDG-uptake features suggested a potential to predict recurrence with enough accuracy to consider tailoring CRT by dose escalation within likely radioresistant regions.
引用
- Beaumont J, Acosta O, Devillers A, et al. Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers. EJNMMI Res. 2019. PMID: 31535233. doi:10.1186/s13550-019-0556-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。